Degermann S, Reilly C, Scott B, Ogata L, von Boehmer H, Lo D
Department of Immunology, IMM-16, Scripps Research Institute, La Jolla, CA 92037.
Eur J Immunol. 1994 Dec;24(12):3155-60. doi: 10.1002/eji.1830241236.
Autoimmune (type 1) diabetes mellitus in mouse, rat, and humans shares several features, including T lymphocyte infiltration into pancreatic islets and a dependence on permissive class II major histocompatibility complex (MHC) alleles. We report here on an experimental model involving mice that express influenza hemagglutinin (HA) under the control of the insulin promoter and, at the same time, a transgenic class II MHC-restricted T cell receptor (TcR) specific for an HA peptide. These mice spontaneously develop islet infiltrates resembling those found in NOD mice and most animals become diabetic within 8 weeks of age. Because of the availability of a clonotypic TcR antibody, we can be confident that the Ins-HA transgene does not induce any measurable alterations in the vast majority of T cells with the transgenic TcR in primary and secondary lymphoid organs. Continuous export of large numbers of HA-specific lymphocytes from the thymus was not required for the manifestation of the disease since mice thymectomized at 3 days after birth still developed the disease albeit with smaller infiltrates.
小鼠、大鼠和人类的自身免疫性(1型)糖尿病具有若干共同特征,包括T淋巴细胞浸润胰腺胰岛以及对允许性II类主要组织相容性复合体(MHC)等位基因的依赖性。我们在此报告一种实验模型,该模型涉及在胰岛素启动子控制下表达流感血凝素(HA)的小鼠,同时还涉及一种针对HA肽的转基因II类MHC限制性T细胞受体(TcR)。这些小鼠自发出现类似于非肥胖糖尿病(NOD)小鼠中发现的胰岛浸润,并且大多数动物在8周龄内会患糖尿病。由于有克隆型TcR抗体,我们可以确信Ins - HA转基因在初级和次级淋巴器官中不会在绝大多数带有转基因TcR的T细胞中诱导任何可测量的改变。疾病的表现并不需要从胸腺持续输出大量HA特异性淋巴细胞,因为出生后3天进行胸腺切除的小鼠仍会患上该疾病,尽管浸润较小。